Articles By Cyndi Root
-
Baxter Sells Vero Cell Vaccines Platform, Manufacturing Facility To Nanotherapeutics
12/18/2014
Baxter International is selling its Vero cell technology to Nanotherapeutics, Inc. The companies announced the definitive agreement in a press release, stating that the deal includes Baxter’s manufacturing facility in Bohumil, Czech Republic.
-
BioLineRx, Novartis Collaborate On Israeli-Sourced Drug Candidates
12/17/2014
BioLineRx and Novartis Pharma AG have partnered to develop and market Israeli drug candidates.
-
CMC Biologics, OncoSynergy Partner To Manufacture Ebola Treatment
12/17/2014
CMC Biologics and OncoSynergy have partnered for the process development and manufacture of OS2966, a treatment for the Ebola virus.
-
Daiichi Sankyo Espha Launches Nine New Generic Drugs
12/17/2014
Daiichi Sankyo and its generics subsidiary, Daiichi Sankyo Espha, have launched nine new generic drugs.
-
Voyager, MassBiologics Partner On Viral Vector Manufacturing
12/17/2014
Voyager Therapeutics and MassBiologics of the University of Massachusetts Medical School (UMMS) have partnered on recombinant adeno-associated viral (rAAV) vector products.
-
Bayer To Provide Emodepside For DNDi To Treat River Blindness
12/16/2014
Bayer HealthCare has partnered with the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R&D organization working on treatments for neglected diseases.
-
UPM Pharmaceuticals To Manufacture BioPharmX's Solid Dose Product
12/15/2014
UPM Pharmaceuticals has agreed to manufacture BioPharmX’s solid dose product at its new large-scale manufacturing facility in Bristol, Tennessee.
-
CCI, Indian Regulatory Authority Approves Sun Acquisition Of Ranbaxy With Conditions
12/12/2014
The Competition Commission of India (CCI) has approved Sun Pharmaceuticals acquisition of Ranbaxy, though with several conditions.
-
Biopharm Group To Distribute NovaBay's NeutroPhase Anti-Infective In Middle East
12/12/2014
NovaBay Pharmaceuticals has partnered with Biopharm Group, headquartered in Cairo, Egypt, to distribute NovaBay’s NeutroPhase anti-infective in the Middle East.
-
Weekly FDA Enforcement Report For Drugs 12/02/14
12/11/2014
The Food and Drug Administration (FDA) has released its product Enforcement Report for December 2, 2014.